文献速递医院感染防控细菌感染、耐药与抗菌药物

中国ICU呼吸机相关性肺炎流行病学多中心前瞻性观察研究

The Current Epidemiological Landscape of Ventilator-associated Pneumonia in the Intensive Care Unit: A Multicenter Prospective Observational Study in China.
PubMed 文献 · Clin Infect Dis · 2018-01-01

该多中心前瞻性观察研究于2013年3月至2015年12月纳入2492例有创机械通气超过48小时的患者,其中129例(5.0%)符合VAP标准,VAP发生率为4.5/1000通气日,28天死亡率为45%。117例(90.7%)检出病原体,其中87株(75.7%)为多重耐药菌,以鲍曼不动杆菌、肺炎克雷伯菌和铜绿假单胞菌最常见;早发与晚发VAP之间及生存与死亡患者之间病原体分布无差异。多因素回归显示年龄较大和SOFA评分与28天死亡率升高相关。

要点

  • VAP发生率为4.5/1000通气日,28天死亡率达45%。
  • 检出病原体中75.7%为多重耐药菌,以鲍曼不动杆菌、肺炎克雷伯菌和铜绿假单胞菌为主。
  • 早发与晚发VAP病原体分布无差异,年龄较大和SOFA评分高与28天死亡率升高相关。

核心结论

  • 早发和晚发VAP均呈现高病原体耐药率和高死亡率。

研究设计与样本

  • 多中心、纵向、前瞻性观察研究,2013年3月至2015年12月纳入2492例有创机械通气超过48小时的患者。

主要发现

  • 129例(5.0%)符合VAP标准,其中38例(29.5%)为早发VAP。
  • VAP发生率为4.5/1000通气日,28天死亡率为45%。
  • 117例(90.7%)检出病原体,包括115株细菌和2株真菌,其中87株(75.7%)细菌为多重耐药菌。
  • 鲍曼不动杆菌、肺炎克雷伯菌和铜绿假单胞菌是VAP最常见的病原体。
  • 早发与晚发VAP之间及生存与死亡患者之间病原体分布无差异,多因素回归显示年龄较大和SOFA评分与28天死亡率升高相关。

临床怎么用

  • 在ICU机械通气患者中应关注VAP高风险,经验性抗菌治疗需覆盖常见多重耐药菌。
  • 对年龄较大或SOFA评分较高的VAP患者应加强病情评估与救治。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ventilator-associated pneumonia (VAP) is among the most important hospital-acquired infections in the intensive-care unit setting. However, clinical data regarding the epidemiology of VAP in China are limited. METHODS: A multicenter, longitudinal, observational study was performed from March 2013 to December 2015 to prospectively collect data on patients diagnosed with VAP. Specifically, patients supported by invasive mechanical ventilation for longer than 48 hours were included. Clinical data were recorded for each VAP patient. The exact pathogen distribution and the incidence of VAP were calculated. Risk factors associated with mortality were analyzed using univariate and multivariate regression analyses. RESULTS: A total of 2492 patients received mechanical ventilation for longer than 48 hours and were enrolled in the study. A total of 129 (5.0%) patients fulfilled the VAP criteria, and 38 (29.5%) patients were diagnosed with early-onset VAP. The incidence of VAP was 4.5 per 1000 ventilation days, with a 28-day mortality rate of 45%. Individual pathogens, including 115 bacteria and 2 fungi, were identified in 117 (90.7%) enrollees, and 87 (75.7%) bacteria were multidrug-resistant organisms. Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa were the most commonly detected pathogens causing VAP. No difference in the distribution of pathogens was observed between early- and late-onset VAP or between surviving and non-surviving patients. Multivariate regression revealed that older ages and Sequential Organ Failure Assessment Scores were correlated with increased 28-day mortality rates. CONCLUSIONS: High pathogen resistance and mortality were found in both early- and late-onset VAP. CLINICAL TRIALS REGISTRATION: NCT01943331.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Xie J, Yang Y, Huang Y, et al. The Current Epidemiological Landscape of Ventilator-associated Pneumonia in the Intensive Care Unit: A Multicenter Prospective Observational Study in China. Clin Infect Dis. 2018. PMID: 30423055. doi:10.1093/cid/ciy692

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。